NeuroVive Pharmaceutical AB Propriété du management
Quel est le Propriété du management de NeuroVive Pharmaceutical AB?
Le Propriété du management de NeuroVive Pharmaceutical AB est 4.31%
Quelle est la définition de Propriété du management?
La propriété d'un initié est calculée en divisant le nombre total d'actions possédées par des initiés (actionnaires détenant plus de 5% de la société ou un dirigeant ou un administrateur de la société) par le nombre total d'actions en circulation.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Propriété du management des entreprises dans Health Care secteur sur OTC par rapport à NeuroVive Pharmaceutical AB
Que fait NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Entreprises avec propriété du management similaire à NeuroVive Pharmaceutical AB
- GenMark Diagnostics Inc a Propriété du management de 4.29%
- Boingo Wireless Inc a Propriété du management de 4.30%
- ACNB a Propriété du management de 4.30%
- Westinghouse Air Brake Technologies Corp a Propriété du management de 4.30%
- Silvercorp Metals Inc a Propriété du management de 4.30%
- Nexstar Media Inc a Propriété du management de 4.31%
- NeuroVive Pharmaceutical AB a Propriété du management de 4.31%
- Cabaletta Bio Inc a Propriété du management de 4.31%
- NZME a Propriété du management de 4.31%
- Quadro Resources a Propriété du management de 4.31%
- Quadro Resources a Propriété du management de 4.31%
- Silvercorp Metals a Propriété du management de 4.32%
- Rocket Companies a Propriété du management de 4.32%